Skip to main content

Table 2 Determinants of multidrug-resistant tuberculosis from the logistic regression model, Henan province, China, 2013

From: Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study

Variable Case (n = 287) Control (n = 291) COR (95 % CI) AOR (95 % CI)a P Value
Sex      
 Male 229 (79.79) 202 (69.42) 0.57 (1.43–2.76) 1.09 (0.24–1.88) 0.006
 Female 58 (20.21) 89 (30.58) 1   
Age (years)      
 ≤29 39 (13.35) 29 (10.14) 1.43 (0.53–2.81) 2.08 (1.11–2.94) 0.401
 30–59 64 (22.43) 68 (22.85) 0.99 (1.18–2.71) 1.48 (0.62–2.26) 0.642
 ≥60 184 (64.22) 194 (67.01) 1   
Education degree      
 High school or lower 211 (73.55) 157 (54.16) 2.37 (1.49–4.23) 1.87 (1.27–2.69) 0.000
 University or higher 76 (26.45) 134 (45.84) 1   
Occupation      
 Unemployed 182 (63.18) 151 (51.76) 1.61 (0.55–4.05) 1.30 (0.78–2.52) 0.007
 Employed 105 (36.81) 140 (48.24) 1   
Estimated distance of residence from the health facility      
 Long 236 (82.19) 126 (43.52) 6.06 (5.04–7.85) 6.66 (5.92–7.72) 0.000
 Short 51 (17.81) 165 (56.48) 1   
Smoking      
 Ever 212 (73.58) 143 (49.38) 2.93 (1.98–4.36) 2.07 (1.66–3.19) 0.000
 Never 75 (26.42) 148 (50.62) 1   
Alcoholism      
 Yes 113 (39.16) 125 (43.25) 0.86 (0.37–2.03) 0.43 (0.37–1.42) 0.429
 No 174 (60.84) 166 (56.75) 1   
Ventilation in Room      
 Yes 139 (48.37) 146 (50.29) 0.93 (0.62–1.93) 1.55 (0.65–2.52) 0.738
 No 148 (51.63) 145 (49.71) 1   
Knowledge on MDR-TB      
 Poor 211 (73.48) 143 (49.42) 2.87 (2.46–3.88) 2.06 (1.66–2.92) 0.000
 Good 76 (26.52) 148 (50.58) 1 1  
Means of transportation to reach the health facility      
 On foot 175 (61.29) 143 (49.46) 1.62 (1.38–3.43) 1.85 (1.12–3.09) 0.006
 By car 112 (38.71) 148 (50.54) 1 1  
Estimated time it takes to reach the health facility (hrs)      
 >3 142 (49.67) 152 (52.46) 0.9 (0.44–2.54) 1.42 (0.51–2.35) 0.000
 ≤3 145 (50.33) 139 (47.54) 1 1  
Social Stigma      
 Yes 183 (63.67) 140 (48.27) 1.9 (1.47–4.12) 1.17 (0.27–2.03) 0.000
 No 104 (36.33) 151 (51.73) 1 1  
Previous TB treatment      
 Yes 214 (74.36) 127 (43.82) 3.79 (3.36–5.35) 4.51 (3.55–5.56) 0.000
 No 73 (25.64) 164 (56.18) 1 1  
Having previous known contact with an MDR-TB patient      
 Yes 170 (59.16) 122 (42.09) 2.01 (1.77–3.65) 1.37 (0.61–2.16) 0.562
 No 117 (40.84) 169 (57.91) 1 1  
Having an opportunistic infection      
 Yes 185 (64.37) 147 (50.68) 1.78 (1.28–3.55) 1.45 (0.58–2.4) 0.001
 No 102 (35.63) 144 (49.32) 1 1  
Defaulting from treatment      
 Yes 145 (50.18) 160 (55.28) 0.84 (0.09–3.04) 0.28 (0.38–1.18) 0.322
 No 142 (49.82) 131 (44.72) 1 1  
Number of TB foci in the lung      
 >3 172 (59.83) 143 (49.27) 1.55 (1.13–3.72) 1.98 (1.49–3.25) 0.012
 ≤3 115 (40.17) 148 (50.73) 1 1  
Total length of first treatment      
 ≥8 months 157 (54.38) 120 (41.28) 1.72 (1.02–3.49) 1.39 (0.65–2.54) 0.001
 <8 months 130 (45.62) 171 (58.72) 1 1  
Adverse effects of anti-TB medication      
 Yes 177 (61.47) 148 (50.87) 1.55 (1.26–3.14) 2.39 (1.40–3.26) 0.011
 No 110 (38.53) 143 (49.13) 1 1  
Prior episodes of anti-TB treatment      
 ≥3 times 176 (61.26) 152 (52.38) 1.45 (0.7–3.16) 1.83 (1.26–2.80) 0.034
 <3 times 111 (38.74) 139 (47.62) 1 1  
  1. Note. aAdjusted for age, sex